Zymeworks BC Inc
ZYME
Market Cap$802.22M
Close$
$-13.17
212.1% downside
Current Fair Value
212.1% downsideOvervalued by 212.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $802.22 Million |
|---|---|
| Enterprise Value | $781.59 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1617.67 |
| Beta | 1.17 |
| Outstanding Shares | 75,846,681 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.13 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | 2.94 |
| Enterprise Value to Revenue | 18.2 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Zymeworks Inc
CEO: Ali Tehrani